What is the initial lab workup for hypercalcemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Laboratory Workup for Hypercalcemia

The initial laboratory workup for hypercalcemia should include serum intact parathyroid hormone (iPTH), parathyroid hormone-related protein (PTHrP), 25-hydroxyvitamin D, and 1,25-dihydroxyvitamin D measurements to determine the underlying cause. 1

Core Laboratory Tests

  • Serum calcium (total and ionized): Confirm hypercalcemia and assess severity. Corrected calcium calculation should be used when albumin is abnormal to rule out pseudo-hypercalcemia 1
  • Intact parathyroid hormone (iPTH): The most important initial test to differentiate PTH-dependent (elevated or inappropriately normal PTH) from PTH-independent causes (suppressed PTH) 2
  • Serum phosphate: Typically low in primary hyperparathyroidism and variable in malignancy-associated hypercalcemia 3
  • Serum creatinine: To assess kidney function, which may be impaired by hypercalcemia 1

Additional First-Line Tests

  • 25-hydroxyvitamin D: To evaluate vitamin D status, as deficiency can mask primary hyperparathyroidism 1, 2
  • 1,25-dihydroxyvitamin D: Elevated in granulomatous diseases and some lymphomas 1
  • Parathyroid hormone-related protein (PTHrP): Important when malignancy is suspected as a cause 1, 4
  • Complete blood count: To assess for anemia, which is common in malignancy but not in primary hyperparathyroidism 3
  • Serum albumin: For accurate interpretation of total calcium levels 1, 5

Diagnostic Approach Based on PTH Results

Elevated or Inappropriately Normal PTH

  • Suggests primary hyperparathyroidism (PHPT) 6, 1
  • Additional tests to consider:
    • 24-hour urinary calcium excretion: To differentiate PHPT from familial hypocalciuric hypercalcemia 5
    • Serum chloride: May show hyperchloremic metabolic acidosis in PHPT 3

Suppressed PTH (<20 pg/mL depending on assay)

  • Indicates PTH-independent hypercalcemia 2
  • Additional tests based on clinical suspicion:
    • PTHrP: For malignancy-associated hypercalcemia 4
    • 1,25-dihydroxyvitamin D: For granulomatous diseases or lymphomas 1
    • Thyroid function tests: For thyrotoxicosis 5
    • Serum and urine protein electrophoresis: For multiple myeloma 4

Important Considerations

  • PTH assays differ in the antibodies used and consequently the extent to which PTH fragments are measured, which can affect results 6
  • PTH is more stable in EDTA plasma than in serum and at 4°C than at room temperature 6
  • Several biological factors can influence PTH concentration, including race, age, BMI, and vitamin D status 6
  • Sampling site and time can affect PTH measurements; central blood has higher PTH concentrations than peripheral blood 6

Common Pitfalls to Avoid

  • Relying solely on total calcium without considering albumin levels or measuring ionized calcium 5
  • Failing to recognize that vitamin D deficiency can mask primary hyperparathyroidism by normalizing calcium levels 2
  • Not considering medication-induced hypercalcemia (thiazide diuretics, lithium, calcium supplements, vitamin D) 2, 5
  • Using inappropriate reference intervals for PTH that don't account for vitamin D status 5
  • Overlooking familial hypocalciuric hypercalcemia, which can mimic primary hyperparathyroidism but requires different management 7

By systematically approaching the laboratory workup of hypercalcemia with these tests, clinicians can efficiently determine the underlying cause and guide appropriate management.

References

Guideline

Hypercalcemia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hypercalcemia: A Review.

JAMA, 2022

Research

Hypercalcemia: an evidence-based approach to clinical cases.

Iranian journal of kidney diseases, 2009

Research

Hypercalcemia of Malignancy: An Update on Pathogenesis and Management.

North American journal of medical sciences, 2015

Research

Investigation of hypercalcemia.

Clinical biochemistry, 2012

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Differential diagnosis of hypercalcemia.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.